Insider Stock Trading History of Smith Robin L


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Smith Robin L since year 2005. The trader's CIK number is 1365035. At the time of this reporting, Smith Robin L is the Director of Signal Genetics, Inc. . (stock ticker symbol SGNL). See this page for all insider trading activities at Signal Genetics, Inc. .

Note that in the past Smith Robin L also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Smith Robin L since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-02-03 SGNL Signal Genetics, Inc. Option Ex 1,200 7.65 9,180
2016-12-13 MYAN Cns Response, Inc. Buy 5,000 6.00 30,000
2016-09-21 CNSO Cns Response, Inc. Option Ex 20,776 5.00 103,880
2015-08-06 SGNL Signal Genetics, Inc. Option Ex 4,125 .00 0
2015-07-17 SGNL Signal Genetics, Inc. Option Ex 1,375 .00 0
2012-09-18 (NBS Phase Iii Medical Inc/de Buy 36,000 .69 24,839
2011-12-14 NBS Phase Iii Medical Inc/de Buy 50,000 .60 29,900
2011-02-28 NBS Phase Iii Medical Inc/de Buy 6,136 1.28 7,854
2008-05-21 NBS Phase Iii Medical Inc/de Buy 16,667 .00 0
2007-08-14 NBS Phase Iii Medical Inc/de Buy 3,300 16,500.00 54,450,000
2007-02-06 NEOI Phase Iii Medical Inc/de Buy 20,000 .00 0
2007-01-26 NEOI Phase Iii Medical Inc/de Buy 200,000 .00 0
2007-01-26 NEOI Phase Iii Medical Inc/de Buy 200,000 .00 0
2006-06-02 PHSM Phase Iii Medical Inc/de Buy 500,000 .04 22,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Smith Robin L (Director of Signal Genetics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.